Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2010
11/11/2010US20100285093 Methods and compositions for repair of cartilage using an in vivo bioreactor
11/11/2010US20100285092 biological repair of cartilage using a hybrid construct combining both an inert structure and living core;cell-matrix encapsulation devices for growing, proliferating, and/or differentiating cells into chondrocyte-like cells under mechanical stress; has inflatable/expandable balloon-like bio-polymers
11/11/2010US20100285057 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
11/11/2010US20100285053 Immunosuppressive Extract Of Cordyceps Sinensis And Uses Thereof
11/11/2010US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies
11/11/2010US20100284988 Utilization of shield effect for dopamine detection and reagent development
11/11/2010US20100284983 Coenzyme q10-containing water-soluble composition and process for production thereof
11/11/2010US20100284938 Penetrating pharmaceutical foam
11/11/2010US20100284924 Nano-devices having impellers for capture and release of molecules
11/11/2010DE102009019322A1 Verfahren zur Herstellung von Synthetischen Cannabinoiden A process for the production of synthetic cannabinoids
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/10/2010EP2248828A1 Method for treating inflammation
11/10/2010EP2248807A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2010EP2248537A1 Restoration of cancer-suppressing functions to neoplastic cells through DNA hypomethylation
11/10/2010EP2248524A2 Preventives/remedies for stress urinary incontinence and method of screening the same
11/10/2010EP1637517B1 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010EP1487483B1 Chimeric infectious dna clones of porcine circovirus and uses thereof
11/10/2010EP1401433B1 Azole acid derivatives, alone or in combination, for treating diabetes and dyslipidemias; and for treating malignant diseases
11/10/2010EP1181274B1 Iminocyclitol inhibitors of hexoaminidase and glycosidase
11/10/2010EP1153613B1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
11/10/2010CN1989991B Process for preparing rhodiola root extract
11/10/2010CN1985888B Medicine for raising hypoxia tolerance and remitting physical fatigue and its use
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN1951418B Chewing tablet of 'Yu Ping Feng' and preparation method thereof
11/10/2010CN1919203B Method for enhancing nutrient absorption with astragalosides
11/10/2010CN1872071B Medication for enhancing body immunity, and fighting against senium, and preparation method
11/10/2010CN1775946B Enhanced virus-mediated DNA transfer
11/10/2010CN1552315B 治疗组合物 The therapeutic composition
11/10/2010CN101883767A Abcg2 inhibitor
11/10/2010CN101883588A High concentration antibody-containing liquid formulation
11/10/2010CN101880670A 植物血红蛋白 Plants hemoglobin
11/10/2010CN101880324A Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880229A (+)-monobornyl maleinate as well as preparation method and application thereof
11/10/2010CN101880222A Square acid derivate and preparation method thereof
11/10/2010CN101879156A Medicinal composition and application thereof
11/10/2010CN101390875B New use of organic salt and inorganic salt composite solution
11/10/2010CN101198355B Agent for prevention or treatment of glaucoma
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/10/2010CN101161264B A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction
11/10/2010CN101011432B Use of extract of bracken flavone as medicament for lead expelling and lead poisioning alleviation
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829676 Whitefly ecdysone receptor antibody
11/09/2010US7829669 Catalytically active recombinant memapsin and methods of use thereof
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829529 Use of factor VIIa or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
11/09/2010US7829124 administering an effective amount of an aqueous or alcohol extract of Phyllanthus to a mammal infected with the YMDD hepatitis B virus mutant strain resistant; inhibiting viral gene expression in a mammal infected with a hepatitis B virus
11/09/2010US7829109 Catheter injectable depot compositions and uses thereof
11/09/2010CA2493958C Muscarinic agonists
11/09/2010CA2488279C Anti-inflammatory compositions derived from chicory
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2474563C Methods of inhibiting orthopoxvirus replication with nucleoside compounds
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2434028C Amino ceramide-like compounds and therapeutic methods of use
11/09/2010CA2397583C New aminopropylphosphinic acids
11/09/2010CA2393487C Pharmaceutical preparation for the treatment of oncoses
11/09/2010CA2386242C Tumour-specific vector for gene therapy
11/09/2010CA2362794C Inhibitors of separase, method for identifying them and uses
11/09/2010CA2326654C Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
11/09/2010CA2315953C 3'-epimeric k-252a derivatives
11/04/2010WO2010127209A2 Compositions and methods for therapy of macular degeneration
11/04/2010WO2010126818A1 Intranasal delivery system for dantrolene
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126164A1 Indole-2-carboxamide derivative
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders
11/04/2010WO2010126036A1 Combined drug
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126030A1 Spiroimidazolone derivative
11/04/2010WO2010126025A1 Quaternary ammonium salt compound
11/04/2010WO2010126014A1 Novel solvate crystals
11/04/2010WO2010126013A1 Method for producing olmesartan medoxomil
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125991A1 Method for control of fish parasites
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010124520A1 Pharmaceutical composition for treating abnormal energy metabolism and use thereof
11/04/2010US20100280110 (3r)-l-menthyl 3-hydroxybutyrate, process for producing the same, and sensate composition comprising the same
11/04/2010US20100280107 Treating benign prostate hyperplasia with sarms
11/04/2010US20100280106 Oral composition to reduce cold symptoms and duration of same
11/04/2010US20100280098 Receptor targeted oligonucleotides
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280050 Piperidinylamino-Thieno[2,3-D] Pyrimidine Compounds for Treating Fibrosis
11/04/2010US20100280046 Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280006 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279955 Novel lipid tripeptide-based hydrogelator and hydrogel
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 1564